Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 7, 2018
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study
A Ploquin, B Pistilli, E Tresch, et al.
ESMO Open
|
September 18, 2025
Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort
R Varnier, D Pérol, W Jacot, et al.
ESMO Open
|
June 18, 2025
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial
A Llombart-Cussac, J M Pérez-García, M Bellet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 24, 2021
De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis
T Gaillard, M Carton, A Mailliez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer
F Mosele, B Stefanovska, A Lusque, et al.
ESMO Open
|
June 4, 2026
Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial
C Blaye, F-C Bidard, L Hue, et al.
ESMO Open
|
July 25, 2021
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)
D Dano, A Lardy-Cleaud, A Monneur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H Bonnefoi, T Grellety, O Tredan, et al.
ESMO Open
|
April 16, 2025
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial
M Saint-Ghislain, S Chabaud, F Dalenc, et al.
ESMO Open
|
May 13, 2021
Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database
M Carausu, M Carton, A Darlix, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
European Journal of Cancer (Oxford, England : 1990)
|
April 7, 2018
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study
A Ploquin, B Pistilli, E Tresch, et al.
ESMO Open
|
September 18, 2025
Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort
R Varnier, D Pérol, W Jacot, et al.
ESMO Open
|
June 18, 2025
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial
A Llombart-Cussac, J M Pérez-García, M Bellet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 24, 2021
De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis
T Gaillard, M Carton, A Mailliez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer
F Mosele, B Stefanovska, A Lusque, et al.
ESMO Open
|
June 4, 2026
Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial
C Blaye, F-C Bidard, L Hue, et al.
ESMO Open
|
July 25, 2021
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)
D Dano, A Lardy-Cleaud, A Monneur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H Bonnefoi, T Grellety, O Tredan, et al.
ESMO Open
|
April 16, 2025
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial
M Saint-Ghislain, S Chabaud, F Dalenc, et al.
ESMO Open
|
May 13, 2021
Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database
M Carausu, M Carton, A Darlix, et al.
Page
of 5